Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Cancer Research Group Calls For EHR Link To Clinical Trial Databases

Executive Summary

The American Association for Cancer Research recommends that meaningful use criteria include a requirement that electronic health records connect to clinical trial databases to encourage greater participation.

You may also be interested in...

Low E-Health Record Adoption Presents Challenge For R&D Use, AstraZeneca Informatics Scientist Says

Adoption of EHRs “is not where it should be” to make them a valuable part of the drug R&D process, but progress is being made, according to AstraZeneca informatics scientist Sergio Eslava.

ASCO Linking E-Health Data To Promote Real-Time Personalized Cancer Care

The American Society of Clinical Oncology takes the first big step toward a real-time learning network by aggregating data culled from electronic health records, to provide physicians, patients and others with up-to-the-minute evidence on how best to treat cancer.

PCORI Methodology Committee Begins Examining How Best To Interface With EHRs

Committee conducts interviews with 33 stakeholders, which reveal gaps and needs, as well as potential areas where Patient-Centered Outcomes Research Institute can help bridge research with electronic sources of data.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts